Skip to content

Study on the Establishment and Clinical Value of a Cytokine-Based Typing and Prognostic Assessment Model for Severe Pneumonia

Study on the Establishment and Clinical Value of a Cytokine-Based Typing and Prognostic Assessment Model for Severe Pneumonia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100654
Enrollment
Unknown
Registered
2025-04-13
Start date
2025-04-17
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe pneumonia

Interventions

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.Voluntary signing of the informed consent form; 3.Patients who meet the diagnostic criteria for severe pneumonia within no more than 48 hours;

Exclusion criteria

Exclusion criteria: 1.Patients with severe pneumonia secondary to severe infection of other sites; 2.Fibrobronchoscopy could not be performed during enrollment or there were contraindications to fibrobronchoscopy, such as uncorrected bleeding tendencies or severe abnormalities in coagulation function; 3.Pregnant or lactating women; 4.Patients with malignant tumors whose end-stage life expectancy is less than 3 months; 5.Patients with chemoradiotherapy or immunodeficiency disease in the last 3 months; 6.If researchers judged that it was not suitable to participate in this study;

Design outcomes

Primary

MeasureTime frame
day-28 mortality;

Secondary

MeasureTime frame
Mortality during ICU stay;Cumulative incidence of mechanical ventilation (noninvasive ventilation, tracheal intubation) in patients with severe pneumonia;day-90 mortality;length of ICU stay;Days of mechanical ventilation in mechanically ventilated patients;Cumulative incidence of tracheal intubation among patients receiving noninvasive ventilation at baseline(Day0);Changes in SOFA scores at baseline (Day0) and day 7;Cumulative incidence of vasopressor therapy within 28 days in patients not receiving vasopressors at baseline(Day0);Changes in oxygenation index at baseline (Day0) and day 7;

Countries

China

Contacts

Public ContactZheng Lei

Southern Medical University Southern Hospital

nfyyzl@163.com+86 20 61641044

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026